Epoxides and aziridines are important building blocks for inhibitors of cysteine proteases which are promising drug targets for many diseases. In spite of the large amount of experimental data concerning inhibition potency, structure-activity relationships, and structural arrangements of enzyme-inhibitor complexes, little is known about the basic principles which connect the substitution pattern with the resulting activities. To shed some light on this issue which is essential for the rational design of improved compounds, we have studied the inhibition processes theoretically for various inhibitors using quantum mechanical/molecular mechanical hybrid approaches and classical molecular dynamics simulations. The careful analysis of the computational results allows insight into the interactions which govern the regio- and stereospecificity of the interactions. Known structure-activity relationships are rationalized in terms of the same interactions that determine the measured pH dependencies. Inconsistencies in existing X-ray structures are resolved through comparison with the computed structures, which leads to a reassessment of the factors that control the inhibition potency. Similarities and differences in the mode of action of epoxide- and aziridine-based inhibitors are elucidated. Finally the small reaction barriers computed for the irreversible step in E64 analogues call into question the commonly accepted two-step model of inhibition since the second, irreversible step is predicted to be so fast that suitably oriented enzyme-inhibitor complexes will react rather than dissociate and equilibrate.
A convenient and robust synthesis of bis[N,N'-diisopropylbenzamidinato(-)]silicon(II) (1), a donor-stabilized silylene, has been developed (35 g scale). To get further information about the reactivity profile of 1, a series of oxidative addition reactions were studied. Treatment of 1 with PhSe-SePh (Se-Se bond activation), C6F6 (C-F activation), and CO2 (C=O activation/cycloaddition) yielded the neutral six-coordinate silicon(IV) complexes 10, 11, and 13, respectively. Treatment of 1 with N2O resulted in the formation of the dinuclear five-coordinate silicon(IV) complex 12 (oxidative addition/dimerization), which contains a four-membered Si2O2 ring. Compounds 10-13 were characterized by NMR spectroscopic studies in the solid state and in solution and by crystal structure analyses. Silylene 1 is three-coordinate in the solid state (from crystal structure analysis) and exists as the four-coordinate isomer 1' in benzene solution (from computational studies). Based on state-of-the-art relativistic DFT analyses, the four-coordinate species 1' was demonstrated to be the thermodynamically favored isomer in benzene solution (favored by ΔG = 6.6 kcal mol(-1) over the three-coordinate species 1). The reason for this was studied by bonding analyses of 1 and 1'. Furthermore, the (29)Si NMR chemical shifts of 1 and 1' were computed, and in the case of 1' it was analyzed how this NMR spectroscopic parameter is affected by solvation. These studies further supported the assumption that the silylene is four-coordinate in solution.
Well looked-after: reductive HCl elimination of the λ(6)-silicon(IV) complex 1 leads to the λ(3)-silicon(II) species 2, a novel type of donor-stabilized silylene. Reaction of 2 with [W(CO)(6)] and with I(2) yields the λ(5)-silicon(II) complex 3 and the λ(6)-silicon(IV) complex 4, respectively.
Silylenes: Reaction of the donor-stabilized silylene 1 with elemental sulfur, selenium, or tellurium led to the formation of 2 a-c [SiN(4)X skeletons (X = S, Se, Te)], the first stable five-coordinate silicon(IV) compounds with silicon-chalcogen double bonds (see figure).
The first donor-stabilized silylenes with guanidinato ligands, compounds 4 and 6, were synthesized and structurally characterized in the solid state and in solution. As demonstrated by single-crystal X-ray diffraction studies, compound 4 contains a bidentate and a monodentate guanidinato ligand of[a] Universität Würzburg,
Reaction of the donor-stabilized silylene 1 (which is three-coordinate in the solid state and four-coordinate in solution) with BEt3 and BPh3 leads to the formation of the Lewis acid/base complexes 2 and 3, respectively, which are the first five-coordinate silicon compounds with an SiB bond. These compounds were structurally characterized by crystal structure analyses and by multinuclear NMR spectroscopic studies in the solid state and in solution. Additionally, the bonding situation in 2 and 3 was analyzed by quantum chemical studies.
Reaction of the donor-stabilized silylene 1 with [Cr(CO)6], [Mo(CO)6], [W(CO)6], or [Fe(CO)5] leads to the formation of the transition-metal silylene complexes 2-5, which contain five-coordinate silicon(II) moieties with Si-M bonds (M = Cr, Mo, W, Fe). These compounds were characterized by NMR spectroscopic studies in the solid state and in solution and by crystal structure analyses. These experimental investigations were complemented by computational studies to gain insight into the bonding situation of 2-5. The nature of the Si-M bonds is best described as a single bond.
The neutral six-coordinate silicon(IV) complexes 2 and 3 (mixture of cis-3 and trans-3) were synthesized by reaction of the donor-stabilized silylene bis[N,N'-diisopropylbenzamidinato(-)]silicon(II) (1) with SO2 . Compounds 2 and 3 are the first silicon(IV) complexes with chelating sulfito or dithionito ligands, and 3 is even the first molecular compound with a chelating dithionito ligand. Compounds 2 and 3 were structurally characterized by crystal structure analyses and multinuclear NMR spectroscopic studies in the solid state and in solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.